Editorial: Community series in novel biomarkers in tumor immunity and immunotherapy, volume II
Saved in:
| Main Authors: | Eyad Elkord, Takaji Matsutani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1608903/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lymphocyte-activation gene 3 in cancer immunotherapy: function, prognostic biomarker and therapeutic potentials
by: Ke Ren, et al.
Published: (2024-11-01) -
Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach?
by: Haozhe Cui, et al.
Published: (2024-11-01) -
Combinational therapeutic strategies to overcome resistance to immune checkpoint inhibitors
by: Besan H. Alsaafeen, et al.
Published: (2025-04-01) -
Resistance mechanisms to immune checkpoint inhibitors: updated insights
by: Besan H. Alsaafeen, et al.
Published: (2025-01-01) -
Increased Levels of Granulocytic Myeloid-Derived Suppressor Cells in Peripheral Blood and Tumour Tissue of Pancreatic Cancer Patients
by: Yazan S. Khaled, et al.
Published: (2014-01-01)